SARS News and Research

RSS

Incidence and outcomes of breakthrough SARS-CoV-2 infections in vaccinated chronic liver disease patients

A new study assesses breakthrough SARS-CoV-2 infections in vaccinated CLD patients with cirrhosis as compared to CLD patients without cirrhosis.

3 Mar 2022

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

A new study has focused on developing a novel anti-SARS-CoV-2 therapy using HTA directed against the human host DEAD-box RNA helicase.

3 Mar 2022

Study establishes that a low dose SARS-CoV-2 infection increases risk of pneumococcal coinfection

A new study published on the bioRxiv* preprint server has evaluated bacterial susceptibility during SARS-CoV-2 infection.

3 Mar 2022

$The benefits of using fractional doses of COVID-19 vaccines$

The benefits of using fractional doses of COVID-19 vaccines

A new study published in PNAS assessed the benefits of using fractional doses for curbing the current COVID-19 pandemic.

3 Mar 2022

First dose SARS-CoV-2 vaccination coverage among younger children in America

Researchers recently investigated the differences in first dose coverage of coronavirus disease 2019 vaccination among children aged five to 11 years in the United States.

3 Mar 2022

Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa

Researchers found that infection with one Omicron sub-lineage of SARS-CoV-2 induces strong protection against reinfection with the other Omicron sub-lineage.

3 Mar 2022

Study explores coronavirus surveillance in bats from Argentina

In a new study, researchers monitored the circulation of coronaviruses in bats from the central and northern provinces of Argentina.

3 Mar 2022

Multigranular and visualization approach precisely predicts SARS-CoV-2 outcomes

In a new study, researchers presented the Multiscale potential of heat-diffusion for affinity-based trajectory embedding approach that identified multimodal signatures of SARS-CoV-2shut.

3 Mar 2022

Assessing the potential of IFNa subtypes in suppressing SARS-CoV-2

A recent study analyzes IFNa subtypes for their therapeutic potential against SARS-CoV-2 and identified the underlying immune signatures and mechanisms.

3 Mar 2022

A model for predicting the evolution of the Omicron wave

Scientists forecast the temporal evolution of the Omicron wave according to a susceptible-infectious-recovered/removed epidemic compartment model.

3 Mar 2022

Scientists find no connection between pandemic chilblains and SARS-CoV-2 infection

A recent study provides a better understanding of whether SARS-CoV-2 infection is linked with the occurrence of chilblains.

3 Mar 2022

Research uncovers a new molecular interaction mechanism for SARS-CoV2

The virus causing the current COVID-19 pandemic is the SARS-CoV-2. Soon after the pandemic outbreak in 2019, the ACE-2 protein, which is present on some of our cells´ surface, was identified as the receptor facilitating host cell viral entry.

3 Mar 2022

Sugar-decorated proteins in mucus could prevent SARS-CoV-2 viruses from spreading from surfaces

Early in the pandemic, many people fastidiously disinfected surfaces because laboratory studies predicted that SARS-CoV-2 could be easily transmitted in this way.

2 Mar 2022

Using Hla-A*32 allele as a prognostic indicator of COVID-19 severity

In a new study, researchers evaluated the association between human leukocyte antigens alleles and the severity of COVID-19.

2 Mar 2022

How effective is mRNA vaccination in multiple myeloma patients?

In a new study, researchers have been investigating the protection offered by the SARS-CoV-2 vaccine in patients suffering from multiple myeloma.

2 Mar 2022

Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

Researchers evaluated the synergistic activity of drugs acting against non-structural protein 1 of SARS-CoV-2 to decrease the viral infectivity.

2 Mar 2022

Dual therapeutic potential of zapnometinib against COVID-19

Researchers assessed the impact of the drug zapnometinib on human immune response against coronavirus disease 2019.

2 Mar 2022

Similarities between SARS-CoV-2 and human retroelements explored

A new study investigated the similarities between SARS-CoV-2 and human retroelements.

2 Mar 2022

Durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection

An new study published presents evidence that a prior history of infection with SARS-CoV-2 provides immunity that prevents reinfection for at least a year.

2 Mar 2022

Adenosine receptor agonists provide therapeutic target in mouse SARS-CoV-2 infection

A new study describes the efficacy of adenosine receptor agonists in the treatment of SARS-CoV-2 infection.

2 Mar 2022

SARS News and Research

Incidence and outcomes of breakthrough SARS-CoV-2 infections in vaccinated chronic liver disease patients

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

Study establishes that a low dose SARS-CoV-2 infection increases risk of pneumococcal coinfection

The benefits of using fractional doses of COVID-19 vaccines

First dose SARS-CoV-2 vaccination coverage among younger children in America

Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa

Study explores coronavirus surveillance in bats from Argentina

Multigranular and visualization approach precisely predicts SARS-CoV-2 outcomes

Assessing the potential of IFNa subtypes in suppressing SARS-CoV-2

A model for predicting the evolution of the Omicron wave

Scientists find no connection between pandemic chilblains and SARS-CoV-2 infection

Research uncovers a new molecular interaction mechanism for SARS-CoV2

Sugar-decorated proteins in mucus could prevent SARS-CoV-2 viruses from spreading from surfaces

Using Hla-A*32 allele as a prognostic indicator of COVID-19 severity

How effective is mRNA vaccination in multiple myeloma patients?

Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

Dual therapeutic potential of zapnometinib against COVID-19

Similarities between SARS-CoV-2 and human retroelements explored

Durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection

Adenosine receptor agonists provide therapeutic target in mouse SARS-CoV-2 infection

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News